Keratinocyte growth factor gene therapy ameliorates ulcerative colitis in rats

被引:0
|
作者
Chun-Jie Liu
机构
关键词
Keratinocyte growth factor; Ulcerative colitis; Gene therapy; Attenuated Salmonella typhimurium;
D O I
暂无
中图分类号
R574.62 [结肠疾病];
学科分类号
1002 ; 100201 ;
摘要
AIM:To investigate the effect of keratinocyte growth factor(KGF) gene therapy in acetic acid-induced ulcerative colitis in rat model.METHODS:The colitis of Sprague-Dawley rats was induced by intrarectal infusion of 1 mL 5%(v/v) acetic acid.Twenty-four hours after exposed to acetic acid,rats were divided into three experimental groups:control group,attenuated Salmonella typhimurium Ty21a strain(SP) group and SP strain carrying human KGF gene(SPK) group,and they were separately administered orally with 10% NaHCO3,SP or SPK.Animals were sacrificed and colonic tissues were harvested respectively on day 3,5,7 and 10 after administration.Weights of rats,colonic weight/length ratio and stool score were evaluated.Histological changes of colonic tissues were examined by hematoxylin and eosin(HE) staining method.The expression of KGF,KGF receptor(KGFR) and TNF-α were measured either by enzyme-linked immunosorbent assay or Western blotting.Immunohistochemistry was used to detect the cellular localization of KGFR and Ki67.In addition,superoxide dismutase(SOD) activity and malondialdehyde(MDA) contents in the homogenate were measured.RESULTS:Body weight and colonic weight/length ratio were declined in SPK group compared with SP and control groups(body weight:272.78 ± 17.92 g vs 243.72 ± 14.02 g and 240.68 ± 12.63 g,P < 0.01;colonic weight/length ratio:115.76 ± 7.47 vs 150.32 ± 5.99 and 153.67 ± 5.50 mg/cm,P < 0.01).Moreover,pathological changes of damaged colon were improved in SPK group as well.After administration of SPK strain,KGF expression increased markedly from the 3rd d,and remained at a high level till the 10th d.Furthermore,KGFR expression and Ki67 expression elevated,whereas TNF-α expression was inhibited in SPK group.In the group administered with SPK,SOD activity increased significantly(d 5:26.18 ± 5.84 vs 18.12 ± 3.30 and 18.79 ± 4.74 U/mg,P < 0.01;d 7:35.48 ± 3.35 vs 22.57 ± 3.44 and 21.69 ± 3.94 U/mg,P < 0.01;d 10:46.10 ± 6.23 vs 25.35 ± 4.76 and 27.82 ± 6.42 U/mg,P < 0.01) and MDA contents decreased accordingly(d 7:7.40 ± 0.88 vs 9.81 ± 1.21 and 10.45 ± 1.40 nmol/mg,P < 0.01;d 10:4.36 ± 0.62 vs 8.41 ± 0.92 and 8.71 ± 1.27 nmol/mg,P < 0.01),compared with SP and control groups.CONCLUSION:KGF gene therapy mediated by attenuated Salmonella ameliorates ulcerative colitis induced by acetic acids,and it may be a safe and effective treatment for ulcerative colitis.
引用
收藏
页码:2632 / 2640
页数:9
相关论文
共 50 条
  • [21] Inula viscosa ameliorates acetic acid induced ulcerative colitis in rats
    Cellat, Mustafa
    Tekeli, Ibrahim Ozan
    Turk, Erdinc
    Aydin, Tuba
    Uyar, Ahmet
    Isler, Cafer Tayer
    Gokcek, Ishak
    Etyemez, Muhammed
    Guvenc, Mehmet
    BIOTECHNIC & HISTOCHEMISTRY, 2023, 98 (04) : 255 - 266
  • [22] Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats
    Tahara, Y
    Ido, A
    Yamamoto, S
    Miyata, Y
    Uto, H
    Hori, T
    Hayashi, K
    Tsubouchi, H
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (01): : 146 - 151
  • [23] Molecular Mechanisms of Basic Fibroblast Growth Factor Effect on Healing of Ulcerative Colitis in Rats
    Paunovic, Brankica
    Deng, Xiaoming
    Khomenko, Tetyana
    Ahluwalia, Amrita
    Tolstanova, Ganna
    Tarnawski, Andrzej
    Szabo, Sandor
    Sandor, Zsuzsanna
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (02): : 430 - 437
  • [24] The effect of vascular endothelial growth factor (VEGF) on experimental ulcerative colitis in rats.
    Sandor, Z
    Singh, G
    Szabo, S
    GASTROENTEROLOGY, 1998, 114 (04) : A1075 - A1075
  • [25] LIPOSOME-BASED INTRAVESICAL THERAPY TARGETING NERVE GROWTH FACTOR (NGF) AMELIORATES BLADDER HYPERSENSITIVITY IN RATS WITH EXPERIMENTAL COLITIS
    Kawamorita, N.
    Yoshikawa, S.
    Tyagi, P.
    Chancellor, M. B.
    Yoshimura, N.
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (06) : 829 - 831
  • [26] Specific immunotherapy ameliorates ulcerative colitis
    Min Cai
    Lu Zeng
    Lin-Jing Li
    Li-Hua Mo
    Rui-Di Xie
    Bai-Sui Feng
    Peng-Yuan Zheng
    Zhi-Gang Liu
    Zhan-Ju Liu
    Ping-Chang Yang
    Allergy, Asthma & Clinical Immunology, 12
  • [27] Specific immunotherapy ameliorates ulcerative colitis
    Cai, Min
    Zeng, Lu
    Li, Lin-Jing
    Mo, Li-Hua
    Xie, Rui-Di
    Feng, Bai-Sui
    Zheng, Peng-Yuan
    Liu, Zhi-Gang
    Liu, Zhan-Ju
    Yang, Ping-Chang
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2016, 12
  • [28] Molecular Mechanisms of Basic Fibroblast Growth Factor Effect on Healing of Experimental Ulcerative Colitis in Rats
    Paunovic, Brankica
    Deng, Xiaoming
    Khomenko, Tetyana
    Tolstanova, Ganna
    Szabo, Sandor
    Sandor, Zsuzsa
    GASTROENTEROLOGY, 2011, 140 (05) : S143 - S143
  • [29] Therapy for ulcerative colitis
    Sandborn, WJ
    CURRENT OPINION IN GASTROENTEROLOGY, 1998, 14 (04) : 312 - 316
  • [30] Therapy of ulcerative colitis
    Novacek, Gottfried
    WIENER KLINISCHE WOCHENSCHRIFT, 2007, : 20 - 24